<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="such as immunoassays, flow cytometry, fluorescence and transmission electron microscopy," exact="polymerase chain reaction" post="(PCR) techniques, enzymatic assays (i.e. NA activity assay), are"/>
 <result pre="on haemagglutin (HA1-18) and neuraminidase (NA1-11) transmembrane glycoproteins [30]. The" exact="infection" post="occurs when the viral HA binds to the host"/>
 <result pre="the movement of the virus to and from sites of" exact="infection" post="in the respiratory tract [32]. The last family consists"/>
 <result pre="addition to the medium at the same time of viral" exact="infection" post="and addition immediately after viral infection, suggesting that the"/>
 <result pre="CCL5 retinal expression in human pigment epithelial cells after viral" exact="infection" post="[36]. Various studies demonstrated the capability of resveratrol to"/>
 <result pre="potential use of (+)-vitisin A in inflammatory disorders after virus" exact="infection" post="[38]. Fig.Â 5 Structures of oligostilbenoids isolated from Vitis"/>
 <result pre="etÂ al. [45] investigated the effect of resveratrol on MERS-CoV" exact="infection" post="and showed that the cytotoxicity of MERS-CoV-infected Vero E6"/>
 <result pre="of MERS-CoV-infected Vero E6 cells (CRL-1586) was reduced by resveratrol" exact="treatment" post="(250Â Î¼M) to 25%. To determine where the resveratrol"/>
 <result pre="high levels of cleaved Caspase 3 were reported after MERS-CoV" exact="infection" post="as apoptosis indicator [47], Lin etÂ al. found that"/>
 <result pre="of liver cancer. Worldwide 71 million people have chronic HCV" exact="infection" post="[52]. HCV exists in seven genotypes and more than"/>
 <result pre="drug-resistance and to reduce the side effects in the long" exact="treatment" post="are needed [51,52]. HCV infection starts with HCV nanoparticles"/>
 <result pre="side effects in the long treatment are needed [51,52]. HCV" exact="infection" post="starts with HCV nanoparticles attachment to the liver cells"/>
 <result pre="worldwide in recent years. So far, there is no specific" exact="treatment" post="for dengue fever [60,61]. Various polyphenols have exhibited anti-dengue"/>
 <result pre="years. The transition from latency to HIV replication and subsequent" exact="infection" post="occurs when host cellular transcription factors are activated along"/>
 <result pre="Jurkat [72]. Surprisingly, the authors found that resveratrol prevented productive" exact="infection" post="of resting CD4 T cells in a dose-dependent manner."/>
 <result pre="active at all concentrations tested, piceid and isorhapontigenin inhibited productive" exact="infection" post="at a concentration 30Â Î¼M, while piceatannol was less"/>
 <result pre="to drug resistance. Therefore, Aknin etÂ al. used a high-throughput" exact="screening" post="approach to find ST inhibitors targeting IN outside of"/>
 <result pre="targeting IN outside of its catalytic site. In a preliminary" exact="screening" post="they identified NSC34931 (stilbenavir, Fig.Â 13), a compound already"/>
 <result pre="which attract monocytes and CD4 T lymphocytes to perpetuate the" exact="infection" post="[81]. In 2000, a synthetic stilbene compound, CGA137053 (Fig.Â"/>
 <result pre="(0.00722Â Î¼M) Pterostilbene HIV-1 â†&quot; integrase, prevents CD4 T cells" exact="infection" post="Activated T and transformed T Jurkat (clone E6), IL-4"/>
 <result pre="date, there are no vaccines or specific drugs in NV-infection" exact="treatment" post="[89]. The noroviruses are subdivided into six different genotypes"/>
 <result pre="29.7Â Î¼M. Conversely, cis-resveratrol exhibited significant antiviral activity in CVB3" exact="infection" post="with IC50 value of 12.2Â Î¼M and in EV71"/>
 <result pre="infection with IC50 value of 12.2Â Î¼M and in EV71" exact="infection" post="with IC50 value of 37.6Â Î¼M [94]. Segun etÂ"/>
 <result pre="viral encephalitis in adults [97]. On the other hand, HSV-2" exact="infection" post="affects the genital area and is a major cause"/>
 <result pre="[103]. In general, the compounds were more active against HSV-2" exact="infection" post="than that from HSV-1. Vaticaffinol, a tetramer with reported"/>
 <result pre="on the beneficial effects of Thai traditional plants for the" exact="treatment" post="herpes simplex virus, Chuanasa etÂ al. investigated the antiviral"/>
 <result pre="Therefore, oxyresveratrol may be a suitable anti-HSV agent in topical" exact="treatment" post="[105]. 4 Conclusions Nowadays, huge efforts are required to"/>
 <result pre="challenges and the way forwardAntivir. Res.1592018354410.1016/j.antiviral.2018.09.00230236531 45LinS.C.HoC.T.ChuoW.H.LiS.WangT.T.LinC.C.Effective inhibition of MERS-CoV" exact="infection" post="by resveratrolBMC Infect. Dis.17201711010.1186/s12879-017-2253-828049444 46HockeA.C.BecherA.KnepperJ.PeterA.HollandG.TÃ¶nniesM.BauerT.T.SchneiderP.NeudeckerJ.MuthD.WendtnerC.M.RÃ¼ckertJ.C.DrostenC.GruberA.D.LaueM.SuttorpN.HippenstielS.WolffT.Emerging human middle east respiratory"/>
 <result pre="Dis.17201711010.1186/s12879-017-2253-828049444 46HockeA.C.BecherA.KnepperJ.PeterA.HollandG.TÃ¶nniesM.BauerT.T.SchneiderP.NeudeckerJ.MuthD.WendtnerC.M.RÃ¼ckertJ.C.DrostenC.GruberA.D.LaueM.SuttorpN.HippenstielS.WolffT.Emerging human middle east respiratory syndrome coronavirus causes widespread" exact="infection" post="and alveolar damage in human lungsAm. J. Respir. Crit."/>
 <result pre="79WeislowO.S.KiserR.FineD.L.BaderJ.ShoemakerR.H.BoydM.R.New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux" exact="screening" post="of synthetic and natural products for AIDS-antiviral activityJ.Â Natl."/>
 <result pre="early host antiviral responsesFront. Cell. Infect. Microbiol.9201912710.3389/fcimb.2019.0012731114761 97HorowitzR.AierstuckS.WilliamsE.A.MelbyB.Herpes simplex virus" exact="infection" post="in a university health population: clinical manifestations, epidemiology, and"/>
 <result pre="Defic. Syndr.57201123824410.1097/QAI.0b013e31821acb521860356 99BradyR.C.BernsteinD.I.Treatment of herpes simplex virus infectionsAntivir. Res.612004738110.1016/j.antiviral.2003.09.00614670580 100FrobertE.CortayJ.C.OokaT.NajioullahF.ThouvenotD.LinaB.MorfinF.Genotypic" exact="detection" post="of acyclovir-resistant HSV-1: characterization of 67 ACV-sensitive and 14"/>
 <result pre="human and animal virusesAdv. Virol.20151842411184241710.1155/2015/1842412015 102ChenX.WangZ.YangZ.WangJ.XuY.xiang TanR.LiE.Houttuynia cordata blocks HSV" exact="infection" post="through inhibition of NF-ÎºB activationAntivir. Res.92201134134510.1016/j.antiviral.2011.09.00521951655 103ChenX.QiaoH.LiuT.YangZ.XuL.XuY.GeH.M.TanR.X.LiE.Inhibition of herpes"/>
 <result pre="inhibition of NF-ÎºB activationAntivir. Res.92201134134510.1016/j.antiviral.2011.09.00521951655 103ChenX.QiaoH.LiuT.YangZ.XuL.XuY.GeH.M.TanR.X.LiE.Inhibition of herpes simplex virus" exact="infection" post="by oligomeric stilbenoids through ROS generationAntivir. Res.952012303610.1016/j.antiviral.2012.05.00122584350 104De ClercqE.Antiviral"/>
 <result pre="plant: mechanism of action and therapeutic efficacy on cutaneous HSV-1" exact="infection" post="in miceAntivir. Res.802008627010.1016/j.antiviral.2008.05.00218565600 106ShenJ.ZhouQ.LiP.WangZ.LiuS.HeC.ZhangC.XiaoP.Update on phytochemistry and pharmacology of"/>
</results>
